第二次研究二次性低胺环球蛋白血症
Rose Monahan1, Iris M Otani1, Heather K Lehman2
1Division of Pulmonary, Critical Care, Allergy, and Sleep Medicine, Department of Medicine, University of California San Francisco Medical Center, San Francisco, California.
概括
二次性低型球蛋白血症 (SHG) 涉及免疫球蛋白水平降低,增加特定患者群体的感染风险. 早期识别和管理,包括预防和免疫球蛋白治疗,对于缓解并发症至关重要.
科学领域:
- 免疫学 免疫学 免疫学
- 临床医学 临床医学
- 药理学 药理学是指药理学的学科.
背景情况:
- 低型球蛋白血症意味着免疫球蛋白水平降低,这是由于原发性免疫缺陷或二次原因造成的.
- 二次性低胺球蛋白血症 (SHG) 经常在接受免疫抑制疗法,移植或患有自身免疫性疾病,恶性瘤或蛋白质丧失综合征的患者中观察到.
- SHG与感染易感性增加有关,需要在风险人群中仔细考虑.
研究的目的:
- 审查目前和新出现的关于二次性低甘球蛋白血症 (SHG) 评估和管理的数据.
- 突出关键人群,在这些人群中,应该怀疑和查SHG.
- 讨论减轻与SHG相关的传染性风险的策略.
主要方法:
- 审查现有文献和关于二次性低二球蛋白血症的新兴数据.
- 分析患有SHG风险的患者群体,包括那些接受免疫抑制疗法,移植,自身免疫疾病,恶性瘤和蛋白质损失综合征的患者.
- 讨论诊断方法,包括病史和实验室查.
- 对管理策略的评估,包括对潜在条件的处理和风险减轻协议.
主要成果:
- 通过有针对性的病史采集和风险人群的实验室查来确定SHG是可行的.
- 虽然解决潜在原因是理想的,但它可能并不总是可以逆转SHG或在临床上可行.
- 在SHG持续存在的情况下,疫苗接种,抗生素预防和免疫球蛋白替代疗法等干预措施对于预防感染至关重要.
结论:
- 二次性低胺球蛋白血症需要在具有特定病史的患者中积极识别和管理.
- 将潜在疾病管理与有针对性的预防措施相结合的多方面的方法对于减少传染性并发症至关重要.
- 需要进行进一步的研究,以充分阐明SHG的最佳评估和管理策略.
相关概念视频
01:36Humoral Immune Responses
71.4K
Overview
71.4K
01:15Hypoglycemia and Glucagon
150
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
150
01:15Transcytosis of IgG
2.7K
Transcytosis is the process in which molecules are internalized by endocytosis, transported across the cell, and released through exocytosis from the opposite end of the cell. Molecules such as insulin, immunoglobulins, and certain nutrients are transferred through the recycling endosomes by recycling and transcytosis.
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
2.7K
01:31Hybridoma Technology
14.1K
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
14.1K
01:22Development of Immunocompetence
283
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
283